Calliditas Therapeutics AB (CALT)
CALT has a market cap or net worth of $501.72 million. The enterprise value is $418.27 million.
CALT has 26.42 million shares outstanding. The number of shares has increased by 7.88% in one year.
|Shares Change (YoY)||+7.88%|
|Shares Change (QoQ)||n/a|
|Owned by Insiders (%)||n/a|
|Owned by Institutions (%)||3.69%|
|EV / Earnings||n/a|
|EV / Sales||8,888.20|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
|Debt / Equity||0.00|
|Debt / EBITDA||0.00|
|Debt / FCF||0.00|
Return on equity (ROE) is -51.40%, which is considered low.
|Return on Equity (ROE)||-51.40%|
|Return on Assets (ROA)||-42.70%|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||$724|
|Profits Per Employee||-$1.07M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -30.82% in the last 52 weeks. The beta is 1.45, so CALT's price volatility has been higher than the market average.
|52-Week Price Change||-30.82%|
|50-Day Moving Average||22.54|
|200-Day Moving Average||23.31|
|Average Volume (30 Days)||189,381|
Short Selling Information
|Short % of Shares Out||0.22%|
|Short % of Float||0.37%|
|Short Ratio (days to cover)||0.14|
In the last 12 months, CALT had revenue of 47,059 and -69.85 million in losses. Earnings per share was -$2.88.
|Earnings Per Share (EPS)||-$2.88|
The company has $83.45 million in cash and no debt, giving a net cash position of $83.45 million or $3.16 per share.
|Cash & Cash Equivalents||83.45M|
|Net Cash Per Share||$3.16|
|Book Value Per Share||4.18|
|Operating Cash Flow||-57.70M|
|Free Cash Flow||-57.70M|
|FCF Per Share||n/a|
Gross margin is 100.00%, with operating and profit margins of -137,753.00% and -148,437.00%.
Dividends & Yields
CALT does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|